Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Debt Ratio: 2020-2022

  • RedHill Biopharma's Debt Ratio rose 57.14% to 0.73 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.73, marking a year-over-year increase of 57.14%. This contributed to the annual value of 0.73 for FY2022, which is 57.14% up from last year.
  • Latest data reveals that RedHill Biopharma reported Debt Ratio of 0.73 as of Q4 2022, which was up 57.14% from 0.46 recorded in Q4 2021.
  • In the past 5 years, RedHill Biopharma's Debt Ratio ranged from a high of 0.73 in Q4 2022 and a low of 0.45 during Q4 2020.
  • In the last 3 years, RedHill Biopharma's Debt Ratio had a median value of 0.46 in 2021 and averaged 0.55.
  • Data for RedHill Biopharma's Debt Ratio shows a peak YoY spiked of 57.14% (in 2022) over the last 5 years.
  • Over the past 3 years, RedHill Biopharma's Debt Ratio (Quarterly) stood at 0.45 in 2020, then rose by 2.21% to 0.46 in 2021, then soared by 57.14% to 0.73 in 2022.
  • Its last three reported values are 0.73 in Q4 2022, 0.46 for Q4 2021, and 0.45 during Q4 2020.